speb/financial-data huggingface dataset:
BLDR balance_sheet (quarterly, 2025-09-30) — Invested Capital: 8759163000.00
BLDR cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -102495000.00
BLDR cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 235000000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 531164000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 4428746000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 4959910000.00
BLDR cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 235000000.00
BLDR cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -468701000.00
BLDR cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: -19653000.00
BLDR cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -1000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Net Debt: 4146812000.00
BLDR income_statement (quarterly, 2025-09-30) — Net Income: 122384000.00
BLDR income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 122384000.00
BLDR income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 122384000.00
BLDR income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 122384000.00
BLDR income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 122384000.00
BLDR cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 122384000.00
BLDR income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 122384000.00
BLDR income_statement (quarterly, 2025-09-30) — Net Interest Income: -69258000.00
BLDR cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -233701000.00
BLDR cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -233701000.00
BLDR income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -69258000.00
BLDR cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -2385000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Net PPE: 2807949000.00
BLDR cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -82842000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -876155000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 172043000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 172043000.00
BLDR income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 376303000.00
BLDR income_statement (quarterly, 2025-09-30) — Normalized Income: 122384000.00
BLDR cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 547724000.00
BLDR income_statement (quarterly, 2025-09-30) — Operating Income: 228768000.00
BLDR income_statement (quarterly, 2025-09-30) — Operating Revenue: 3941190000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 110552000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 121152000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 14228000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 1195868000.00
BLDR cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 86000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 134402000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 137659000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Other Properties: 2807949000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Other Receivables: 447706000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Payables: 1035777000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 1443350000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
BLDR income_statement (quarterly, 2025-09-30) — Pretax Income: 159510000.00
BLDR cash_flow (quarterly, 2025-09-30) — Purchase Of Business: -19653000.00
BLDR cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -85818000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Receivables: 1702445000.00
BLDR income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 2741707000.00
BLDR income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 147535000.00
BLDR cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -468701000.00
BLDR cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -1000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 122384000.00
BLDR cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 2976000.00
BLDR income_statement (quarterly, 2025-09-30) — Selling General And Administration: 970715000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Share Issued: 110552000.00
BLDR cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 16402000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 4316189000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -876155000.00
BLDR income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
BLDR income_statement (quarterly, 2025-09-30) — Tax Provision: 37126000.00
BLDR income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.23
BLDR balance_sheet (quarterly, 2025-09-30) — Total Assets: 11430883000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 8744935000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Total Debt: 5081157000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 4316189000.00
BLDR income_statement (quarterly, 2025-09-30) — Total Expenses: 3712422000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 7114694000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 8134695000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 5269612000.00
BLDR income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 228768000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 74907000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Working Capital: 1451106000.00
BLDR income_statement (annual, 2025-12-31) — +Operating Expense: 3829501000.00
BLDR income_statement (quarterly, 2025-12-31) — +Operating Expense: 940232000.00
BLDR income_statement (annual, 2025-12-31) — +Total Revenue: 15190638000.00
BLDR income_statement (quarterly, 2025-12-31) — +Total Revenue: 3357888000.00
BLDR balance_sheet (annual, 2025-12-31) — Accounts Payable: 714710000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 714710000.00
BLDR balance_sheet (annual, 2025-12-31) — Accounts Receivable: 1061011000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 1061011000.00
BLDR balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -1446903000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -1446903000.00
BLDR balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 4197279000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 4197279000.00
BLDR balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -42511000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -42511000.00
BLDR income_statement (annual, 2025-12-31) — Basic Average Shares: 111400000.00
BLDR income_statement (quarterly, 2025-12-31) — Basic Average Shares: 110600000.00
BLDR income_statement (annual, 2025-12-31) — Basic EPS: 3.91
BLDR income_statement (quarterly, 2025-12-31) — Basic EPS: 0.28
BLDR cash_flow (annual, 2025-12-31) — Beginning Cash Position: 153624000.00
BLDR cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 296162000.00
BLDR balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 961946000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 961946000.00
BLDR cash_flow (annual, 2025-12-31) — Capital Expenditure: -362602000.00
BLDR cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -88071000.00
BLDR balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 658904000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 658904000.00
BLDR balance_sheet (annual, 2025-12-31) — Capital Stock: 1106000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Capital Stock: 1106000.00
BLDR balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 181753000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 181753000.00
BLDR balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 181753000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 181753000.00
BLDR cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 279417000.00
BLDR cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -3997000.00
BLDR cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -1467174000.00
BLDR cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -305206000.00
BLDR cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 1215886000.00
BLDR cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 194794000.00
BLDR cash_flow (annual, 2025-12-31) — Change In Account Payable: -167179000.00
BLDR cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -244442000.00
BLDR cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -85954000.00
BLDR cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: -20586000.00
BLDR cash_flow (annual, 2025-12-31) — Change In Inventory: 198519000.00
BLDR cash_flow (quarterly, 2025-12-31) — Change In Inventory: 94903000.00
BLDR cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -9314000.00
BLDR cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -5583000.00
BLDR cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -10758000.00
BLDR cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 1565000.00
BLDR cash_flow (annual, 2025-12-31) — Change In Payable: -167179000.00
BLDR cash_flow (quarterly, 2025-12-31) — Change In Payable: -244442000.00
BLDR cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -253133000.00
BLDR cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -265028000.00
BLDR cash_flow (annual, 2025-12-31) — Change In Receivables: 200629000.00
BLDR cash_flow (quarterly, 2025-12-31) — Change In Receivables: 187854000.00
BLDR cash_flow (annual, 2025-12-31) — Change In Working Capital: 125943000.00
BLDR cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 13711000.00
BLDR cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 182499000.00
BLDR cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 172339000.00
BLDR cash_flow (annual, 2025-12-31) — Changes In Cash: 28129000.00
BLDR cash_flow (quarterly, 2025-12-31) — Changes In Cash: -114409000.00
BLDR balance_sheet (annual, 2025-12-31) — Common Stock: 1106000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Common Stock: 1106000.00
BLDR balance_sheet (annual, 2025-12-31) — Common Stock Equity: 4352251000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 4352251000.00
BLDR cash_flow (annual, 2025-12-31) — Common Stock Payments: -413958000.00
BLDR cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 0.00
BLDR balance_sheet (annual, 2025-12-31) — Construction In Progress: 201544000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 201544000.00
BLDR income_statement (annual, 2025-12-31) — Cost Of Revenue: 10574861000.00
BLDR income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 2355876000.00
BLDR balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 403060000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 403060000.00
BLDR balance_sheet (annual, 2025-12-31) — Current Assets: 2927283000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Current Assets: 2927283000.00
BLDR balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 111132000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 111132000.00
BLDR balance_sheet (annual, 2025-12-31) — Current Debt: 14334000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Current Debt: 14334000.00
BLDR balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 125466000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 125466000.00
BLDR balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 168440000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 168440000.00
BLDR balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 168440000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 168440000.00
BLDR balance_sheet (annual, 2025-12-31) — Current Liabilities: 1574941000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 1574941000.00
BLDR balance_sheet (annual, 2025-12-31) — Current Provisions: 95194000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Current Provisions: 95194000.00
BLDR cash_flow (annual, 2025-12-31) — Deferred Income Tax: 6808000.00
BLDR cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -17068000.00
BLDR cash_flow (annual, 2025-12-31) — Deferred Tax: 6808000.00
BLDR cash_flow (quarterly, 2025-12-31) — Deferred Tax: -17068000.00
BLDR cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 591432000.00
BLDR cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 151342000.00
BLDR cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 591432000.00
BLDR cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 151342000.00
BLDR income_statement (annual, 2025-12-31) — Diluted Average Shares: 111800000.00
BLDR income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 110900000.00
BLDR income_statement (annual, 2025-12-31) — Diluted EPS: 3.89
BLDR income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.28
BLDR income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 435199000.00
BLDR income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 31480000.00
BLDR income_statement (annual, 2025-12-31) — EBIT: 786276000.00
BLDR income_statement (quarterly, 2025-12-31) — EBIT: 61780000.00
BLDR income_statement (annual, 2025-12-31) — EBITDA: 1377708000.00
BLDR income_statement (quarterly, 2025-12-31) — EBITDA: 213122000.00
BLDR cash_flow (annual, 2025-12-31) — End Cash Position: 181753000.00
BLDR cash_flow (quarterly, 2025-12-31) — End Cash Position: 181753000.00
BLDR cash_flow (annual, 2025-12-31) — Financing Cash Flow: 279417000.00
BLDR cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -3997000.00
BLDR cash_flow (annual, 2025-12-31) — Free Cash Flow: 853284000.00
BLDR cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 106723000.00
BLDR balance_sheet (annual, 2025-12-31) — Goodwill: 4137377000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Goodwill: 4137377000.00
BLDR balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 5321170000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 5321170000.00
BLDR balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 1103522000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 1103522000.00
BLDR balance_sheet (annual, 2025-12-31) — Gross PPE: 4273275000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Gross PPE: 4273275000.00
BLDR income_statement (annual, 2025-12-31) — Gross Profit: 4615777000.00
BLDR income_statement (quarterly, 2025-12-31) — Gross Profit: 1002012000.00
BLDR cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 67658000.00
BLDR cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: -5102000.00
BLDR income_statement (annual, 2025-12-31) — Interest Expense: 273894000.00
BLDR income_statement (quarterly, 2025-12-31) — Interest Expense: 67755000.00
BLDR income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 273894000.00
BLDR income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 67755000.00
BLDR cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 260515000.00
BLDR cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 54643000.00
BLDR balance_sheet (annual, 2025-12-31) — Interest Payable: 63202000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Interest Payable: 63202000.00
BLDR balance_sheet (annual, 2025-12-31) — Inventory: 1094684000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Inventory: 1094684000.00
BLDR balance_sheet (annual, 2025-12-31) — Invested Capital: 8793618000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Invested Capital: 8793618000.00
BLDR cash_flow (annual, 2025-12-31) — Investing Cash Flow: -1467174000.00
BLDR cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -305206000.00
BLDR cash_flow (annual, 2025-12-31) — Issuance Of Debt: 4808000000.00
BLDR cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
BLDR balance_sheet (annual, 2025-12-31) — Land And Improvements: 493338000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 493338000.00
BLDR balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 547772000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 547772000.00
BLDR balance_sheet (annual, 2025-12-31) — Long Term Debt: 4427033000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 4427033000.00
BLDR balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 4974805000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 4974805000.00
BLDR cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 4808000000.00
BLDR cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
BLDR cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -4060847000.00
BLDR cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -696000.00
BLDR balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 1991462000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 1991462000.00
BLDR cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -1125322000.00
BLDR cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: -219477000.00
BLDR cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -413958000.00
BLDR cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
BLDR balance_sheet (annual, 2025-12-31) — Net Debt: 4259614000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Net Debt: 4259614000.00
BLDR income_statement (annual, 2025-12-31) — Net Income: 435199000.00
BLDR income_statement (quarterly, 2025-12-31) — Net Income: 31480000.00
BLDR income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 435199000.00
BLDR income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 31480000.00
BLDR income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 435199000.00
BLDR income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 31480000.00
BLDR income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 435199000.00
BLDR income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 31480000.00
BLDR income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 435199000.00
BLDR income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 31480000.00
BLDR cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 435199000.00
BLDR cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 31480000.00
BLDR income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 435199000.00
BLDR income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 31480000.00
BLDR income_statement (annual, 2025-12-31) — Net Interest Income: -273894000.00
BLDR income_statement (quarterly, 2025-12-31) — Net Interest Income: -67755000.00
BLDR cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 747153000.00
BLDR cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -696000.00
BLDR cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 747153000.00
BLDR cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -696000.00
BLDR income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -273894000.00
BLDR income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -67755000.00
BLDR cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -53778000.00
BLDR cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -3301000.00
BLDR balance_sheet (annual, 2025-12-31) — Net PPE: 2826372000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Net PPE: 2826372000.00
BLDR cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -341852000.00
BLDR cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -85729000.00
BLDR balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -968919000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -968919000.00
BLDR balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 23000000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 23000000.00
BLDR balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 177975000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 177975000.00
BLDR balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 23000000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 23000000.00
BLDR balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 177975000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 177975000.00
BLDR income_statement (annual, 2025-12-31) — Normalized EBITDA: 1377708000.00
BLDR income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 213122000.00
BLDR income_statement (annual, 2025-12-31) — Normalized Income: 435199000.00
BLDR income_statement (quarterly, 2025-12-31) — Normalized Income: 31480000.00
BLDR cash_flow (annual, 2025-12-31) — Operating Cash Flow: 1215886000.00
BLDR cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 194794000.00
BLDR income_statement (annual, 2025-12-31) — Operating Income: 786276000.00
BLDR income_statement (quarterly, 2025-12-31) — Operating Income: 61780000.00
BLDR income_statement (annual, 2025-12-31) — Operating Revenue: 15190638000.00
BLDR income_statement (quarterly, 2025-12-31) — Operating Revenue: 3357888000.00
BLDR balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 110585000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 110585000.00
BLDR balance_sheet (annual, 2025-12-31) — Other Current Assets: 126811000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 126811000.00
BLDR balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 14334000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 14334000.00
BLDR balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 1183793000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 1183793000.00
BLDR cash_flow (annual, 2025-12-31) — Other Non Cash Items: 2992000.00
BLDR cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 8617000.00
BLDR balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 139705000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 139705000.00
BLDR balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 157558000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 157558000.00
BLDR balance_sheet (annual, 2025-12-31) — Other Properties: 624985000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Other Properties: 624985000.00
BLDR balance_sheet (annual, 2025-12-31) — Other Receivables: 463024000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Other Receivables: 463024000.00
BLDR balance_sheet (annual, 2025-12-31) — Payables: 782781000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Payables: 782781000.00
BLDR balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 1185841000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 1185841000.00
BLDR balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
BLDR balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
BLDR income_statement (annual, 2025-12-31) — Pretax Income: 512382000.00
BLDR income_statement (quarterly, 2025-12-31) — Pretax Income: -5975000.00
BLDR balance_sheet (annual, 2025-12-31) — Properties: 0.00
BLDR balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
BLDR cash_flow (annual, 2025-12-31) — Purchase Of Business: -1125322000.00
BLDR cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -219477000.00
BLDR cash_flow (annual, 2025-12-31) — Purchase Of PPE: -362602000.00
BLDR cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -88071000.00
BLDR balance_sheet (annual, 2025-12-31) — Receivables: 1524035000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Receivables: 1524035000.00
BLDR income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 10574861000.00
BLDR income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 2355876000.00
BLDR income_statement (annual, 2025-12-31) — Reconciled Depreciation: 591432000.00
BLDR income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 151342000.00
BLDR cash_flow (annual, 2025-12-31) — Repayment Of Debt: -4060847000.00
BLDR cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -696000.00
BLDR cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -413958000.00
BLDR cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: 0.00
BLDR balance_sheet (annual, 2025-12-31) — Retained Earnings: 153866000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 153866000.00
BLDR cash_flow (annual, 2025-12-31) — Sale Of PPE: 20750000.00
BLDR cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 2342000.00
BLDR income_statement (annual, 2025-12-31) — Selling General And Administration: 3829501000.00
BLDR income_statement (quarterly, 2025-12-31) — Selling General And Administration: 940232000.00
BLDR balance_sheet (annual, 2025-12-31) — Share Issued: 110585000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Share Issued: 110585000.00
BLDR cash_flow (annual, 2025-12-31) — Stock Based Compensation: 53512000.00
BLDR cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 6712000.00
BLDR balance_sheet (annual, 2025-12-31) — Stockholders Equity: 4352251000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 4352251000.00
BLDR balance_sheet (annual, 2025-12-31) — Tangible Book Value: -968919000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -968919000.00
BLDR income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
BLDR income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
BLDR income_statement (annual, 2025-12-31) — Tax Provision: 77183000.00
BLDR income_statement (quarterly, 2025-12-31) — Tax Provision: -37455000.00
BLDR income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.15
BLDR income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
BLDR balance_sheet (annual, 2025-12-31) — Total Assets: 11237530000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Total Assets: 11237530000.00
BLDR balance_sheet (annual, 2025-12-31) — Total Capitalization: 8779284000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 8779284000.00
BLDR balance_sheet (annual, 2025-12-31) — Total Debt: 5100271000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Total Debt: 5100271000.00
BLDR balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 4352251000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 4352251000.00
BLDR income_statement (annual, 2025-12-31) — Total Expenses: 14404362000.00
BLDR income_statement (quarterly, 2025-12-31) — Total Expenses: 3296108000.00
BLDR balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 6885279000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 6885279000.00
BLDR balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 8310247000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 8310247000.00
BLDR balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 5310338000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 5310338000.00
BLDR income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 786276000.00
BLDR income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 61780000.00
BLDR balance_sheet (annual, 2025-12-31) — Total Tax Payable: 68071000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 68071000.00
BLDR balance_sheet (annual, 2025-12-31) — Working Capital: 1352342000.00
BLDR balance_sheet (quarterly, 2025-12-31) — Working Capital: 1352342000.00
BLDR income_statement (quarterly, 2026-03-31) — +Operating Expense: 912450000.00
BLDR income_statement (quarterly, 2026-03-31) — +Total Revenue: 3287077000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 924611000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 1163011000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 4003145000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -43461000.00
BLDR income_statement (quarterly, 2026-03-31) — Basic Average Shares: 109870000.00
BLDR income_statement (quarterly, 2026-03-31) — Basic EPS: -0.43
BLDR cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 181753000.00
BLDR cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -46745000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 654356000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1075000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 98342000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 98342000.00
BLDR cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -113018000.00
BLDR cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -57847000.00
BLDR cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 87454000.00
BLDR cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 211270000.00
BLDR cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -37744000.00
BLDR cash_flow (quarterly, 2026-03-31) — Change In Inventory: -88382000.00
BLDR cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -2141000.00
BLDR cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 12272000.00
BLDR cash_flow (quarterly, 2026-03-31) — Change In Payable: 211270000.00
BLDR cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 173526000.00
BLDR cash_flow (quarterly, 2026-03-31) — Change In Receivables: -175368000.00
BLDR cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -80093000.00
BLDR cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -157768000.00
BLDR cash_flow (quarterly, 2026-03-31) — Changes In Cash: -83411000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Common Stock: 1075000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 4004220000.00
BLDR cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -300067000.00
BLDR income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 2358111000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 305291000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Current Assets: 3116103000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 111423000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Current Debt: 24285000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 135708000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 180543000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 180543000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 1771864000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Current Provisions: 153084000.00
BLDR cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 51054000.00
BLDR cash_flow (quarterly, 2026-03-31) — Deferred Tax: 51054000.00
BLDR cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 148360000.00
BLDR cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 148360000.00
BLDR income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 109870000.00
BLDR income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.43
BLDR income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -47414000.00
BLDR income_statement (quarterly, 2026-03-31) — EBIT: 16516000.00
BLDR income_statement (quarterly, 2026-03-31) — EBITDA: 164876000.00
BLDR cash_flow (quarterly, 2026-03-31) — End Cash Position: 98342000.00
BLDR cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -113018000.00
BLDR cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 40709000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Goodwill: 4139898000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 5252750000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 1206472000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Gross PPE: 2771683000.00
BLDR income_statement (quarterly, 2026-03-31) — Gross Profit: 928966000.00
BLDR cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 730000.00
BLDR income_statement (quarterly, 2026-03-31) — Interest Expense: 74392000.00
BLDR income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 74392000.00
BLDR cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 85196000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Interest Payable: 50917000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Inventory: 1189402000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Invested Capital: 8641783000.00
BLDR cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -57847000.00
BLDR cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 240000000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 542933000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 4613278000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 5156211000.00
BLDR cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 240000000.00
BLDR cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -40679000.00
BLDR cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: -13071000.00
BLDR cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -300067000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Net Debt: 4539221000.00
BLDR income_statement (quarterly, 2026-03-31) — Net Income: -47414000.00
BLDR income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -47414000.00
BLDR income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -47414000.00
BLDR income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -47414000.00
BLDR income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -47414000.00
BLDR cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -47414000.00
BLDR income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -47414000.00
BLDR income_statement (quarterly, 2026-03-31) — Net Interest Income: -74392000.00
BLDR cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 199321000.00
BLDR cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 199321000.00
BLDR income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -74392000.00
BLDR cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -12272000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Net PPE: 2771683000.00
BLDR cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -44776000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -1248530000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 23662000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 229691000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 23662000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 229691000.00
BLDR income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 164876000.00
BLDR income_statement (quarterly, 2026-03-31) — Normalized Income: -47414000.00
BLDR cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 87454000.00
BLDR income_statement (quarterly, 2026-03-31) — Operating Income: 16516000.00
BLDR income_statement (quarterly, 2026-03-31) — Operating Revenue: 3287077000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 107518000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 128958000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 24285000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 1112852000.00
BLDR cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 1919000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 138896000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 141108000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Other Properties: 2771683000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Other Receivables: 536390000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Payables: 997238000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 1302529000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
BLDR income_statement (quarterly, 2026-03-31) — Pretax Income: -57876000.00
BLDR cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -13071000.00
BLDR cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -46745000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Receivables: 1699401000.00
BLDR income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 2358111000.00
BLDR income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 148360000.00
BLDR cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -40679000.00
BLDR cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -300067000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 0.00
BLDR cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 1969000.00
BLDR income_statement (quarterly, 2026-03-31) — Selling General And Administration: 912450000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Share Issued: 107518000.00
BLDR cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 13628000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 4004220000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -1248530000.00
BLDR income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
BLDR income_statement (quarterly, 2026-03-31) — Tax Provision: -10462000.00
BLDR income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.18
BLDR balance_sheet (quarterly, 2026-03-31) — Total Assets: 11303094000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 8617498000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Total Debt: 5291919000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 4004220000.00
BLDR income_statement (quarterly, 2026-03-31) — Total Expenses: 3270561000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 7298874000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 8186991000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 5527010000.00
BLDR income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 16516000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 72627000.00
BLDR balance_sheet (quarterly, 2026-03-31) — Working Capital: 1344239000.00
BLDS.V income_statement (annual, 2022-03-31) — +Operating Expense: 807111.00
BLDS.V income_statement (annual, 2022-03-31) — +Total Revenue: 0.00
BLDS.V balance_sheet (annual, 2022-03-31) — Accounts Payable: 662255.00
BLDS.V balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -161737.00
BLDS.V income_statement (annual, 2022-03-31) — Basic Average Shares: 2941322.00
BLDS.V income_statement (annual, 2022-03-31) — Basic EPS: -0.35
BLDS.V cash_flow (annual, 2022-03-31) — Beginning Cash Position: 456167.00
BLDS.V cash_flow (annual, 2022-03-31) — Capital Expenditure: -276079.00
BLDS.V balance_sheet (annual, 2022-03-31) — Capital Lease Obligations: 87732.00
BLDS.V balance_sheet (annual, 2022-03-31) — Capital Stock: 49599852.00
BLDS.V balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 3969.00
BLDS.V balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Short Term Investments: 3969.00
BLDS.V cash_flow (annual, 2022-03-31) — Cash Dividends Paid: 0.00
BLDS.V balance_sheet (annual, 2022-03-31) — Cash Financial: 3969.00
BLDS.V cash_flow (annual, 2022-03-31) — Cash Flow From Continuing Financing Activities: 193240.00
BLDS.V cash_flow (annual, 2022-03-31) — Cash Flow From Continuing Investing Activities: -226079.00
BLDS.V cash_flow (annual, 2022-03-31) — Cash Flow From Continuing Operating Activities: -419359.00
BLDS.V cash_flow (annual, 2022-03-31) — Change In Account Payable: 112842.00
BLDS.V cash_flow (annual, 2022-03-31) — Change In Payable: 282140.00
BLDS.V cash_flow (annual, 2022-03-31) — Change In Payables And Accrued Expense: 282140.00
BLDS.V cash_flow (annual, 2022-03-31) — Change In Prepaid Assets: 1565.00
BLDS.V cash_flow (annual, 2022-03-31) — Change In Receivables: -1251.00
BLDS.V cash_flow (annual, 2022-03-31) — Change In Working Capital: 282454.00
BLDS.V cash_flow (annual, 2022-03-31) — Changes In Cash: -452198.00
BLDS.V balance_sheet (annual, 2022-03-31) — Common Stock: 49599852.00
BLDS.V balance_sheet (annual, 2022-03-31) — Common Stock Equity: 9779085.00
BLDS.V cash_flow (annual, 2022-03-31) — Common Stock Issuance: 207381.00
BLDS.V income_statement (annual, 2022-03-31) — Cost Of Revenue: 47544.00
BLDS.V balance_sheet (annual, 2022-03-31) — Current Accrued Expenses: 19000.00
BLDS.V balance_sheet (annual, 2022-03-31) — Current Assets: 167735.00
BLDS.V balance_sheet (annual, 2022-03-31) — Current Capital Lease Obligation: 42265.00
BLDS.V balance_sheet (annual, 2022-03-31) — Current Debt: 20000.00
BLDS.V balance_sheet (annual, 2022-03-31) — Current Debt And Capital Lease Obligation: 62265.00
BLDS.V balance_sheet (annual, 2022-03-31) — Current Liabilities: 912818.00
BLDS.V cash_flow (annual, 2022-03-31) — Depreciation: 47544.00
BLDS.V cash_flow (annual, 2022-03-31) — Depreciation Amortization Depletion: 47544.00
BLDS.V cash_flow (annual, 2022-03-31) — Depreciation And Amortization: 47544.00
BLDS.V income_statement (annual, 2022-03-31) — Diluted Average Shares: 2941322.00
BLDS.V income_statement (annual, 2022-03-31) — Diluted EPS: -0.35
BLDS.V income_statement (annual, 2022-03-31) — Diluted NI Availto Com Stockholders: -821882.00
BLDS.V balance_sheet (annual, 2022-03-31) — Dueto Related Parties Current: 169298.00
BLDS.V income_statement (annual, 2022-03-31) — EBIT: -804733.00
BLDS.V income_statement (annual, 2022-03-31) — EBITDA: -757189.00
BLDS.V cash_flow (annual, 2022-03-31) — End Cash Position: 3969.00
BLDS.V cash_flow (annual, 2022-03-31) — Financing Cash Flow: 193240.00
BLDS.V cash_flow (annual, 2022-03-31) — Free Cash Flow: -695438.00
BLDS.V cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of PPE: -50000.00
BLDS.V income_statement (annual, 2022-03-31) — Gain On Sale Of Ppe: 50000.00
BLDS.V income_statement (annual, 2022-03-31) — Gain On Sale Of Security: -122.00
BLDS.V income_statement (annual, 2022-03-31) — General And Administrative Expense: 305157.00
BLDS.V balance_sheet (annual, 2022-03-31) — Gross PPE: 10706935.00
BLDS.V income_statement (annual, 2022-03-31) — Gross Profit: -47544.00
BLDS.V income_statement (annual, 2022-03-31) — Interest Expense: 17149.00
BLDS.V income_statement (annual, 2022-03-31) — Interest Expense Non Operating: 17149.00
BLDS.V income_statement (annual, 2022-03-31) — Interest Income: 44.00
BLDS.V income_statement (annual, 2022-03-31) — Interest Income Non Operating: 44.00
BLDS.V cash_flow (annual, 2022-03-31) — Interest Paid Cff: 0.00
BLDS.V balance_sheet (annual, 2022-03-31) — Invested Capital: 9799085.00
BLDS.V cash_flow (annual, 2022-03-31) — Investing Cash Flow: -226079.00
BLDS.V cash_flow (annual, 2022-03-31) — Issuance Of Capital Stock: 207381.00
BLDS.V cash_flow (annual, 2022-03-31) — Issuance Of Debt: 20000.00
BLDS.V balance_sheet (annual, 2022-03-31) — Long Term Capital Lease Obligation: 45467.00
BLDS.V balance_sheet (annual, 2022-03-31) — Long Term Debt And Capital Lease Obligation: 45467.00
BLDS.V cash_flow (annual, 2022-03-31) — Long Term Debt Issuance: 20000.00
BLDS.V cash_flow (annual, 2022-03-31) — Long Term Debt Payments: -32390.00
BLDS.V balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 21269.00
BLDS.V cash_flow (annual, 2022-03-31) — Net Common Stock Issuance: 207381.00
BLDS.V balance_sheet (annual, 2022-03-31) — Net Debt: 16031.00
BLDS.V cash_flow (annual, 2022-03-31) — Net Foreign Currency Exchange Gain Loss: 1334.00
BLDS.V income_statement (annual, 2022-03-31) — Net Income: -821882.00
BLDS.V income_statement (annual, 2022-03-31) — Net Income Common Stockholders: -821882.00
BLDS.V income_statement (annual, 2022-03-31) — Net Income Continuous Operations: -821882.00
BLDS.V income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: -821882.00
BLDS.V income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: -821882.00
BLDS.V cash_flow (annual, 2022-03-31) — Net Income From Continuing Operations: -821882.00
BLDS.V income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: -821882.00
BLDS.V income_statement (annual, 2022-03-31) — Net Interest Income: -17105.00
BLDS.V cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: -12390.00
BLDS.V cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: -32390.00
BLDS.V income_statement (annual, 2022-03-31) — Net Non Operating Interest Income Expense: -17105.00
BLDS.V cash_flow (annual, 2022-03-31) — Net Other Financing Charges: -1751.00
BLDS.V balance_sheet (annual, 2022-03-31) — Net PPE: 10545198.00
BLDS.V cash_flow (annual, 2022-03-31) — Net PPE Purchase And Sale: -226079.00
BLDS.V cash_flow (annual, 2022-03-31) — Net Short Term Debt Issuance: 20000.00
BLDS.V balance_sheet (annual, 2022-03-31) — Net Tangible Assets: 9779085.00
BLDS.V income_statement (annual, 2022-03-31) — Normalized EBITDA: -807067.00
BLDS.V income_statement (annual, 2022-03-31) — Normalized Income: -871760.00
BLDS.V cash_flow (annual, 2022-03-31) — Operating Cash Flow: -419359.00
BLDS.V cash_flow (annual, 2022-03-31) — Operating Gains Losses: -48666.00
BLDS.V income_statement (annual, 2022-03-31) — Operating Income: -854655.00
BLDS.V income_statement (annual, 2022-03-31) — Operating Revenue: 0.00
BLDS.V balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 2958334.00
BLDS.V balance_sheet (annual, 2022-03-31) — Other Current Borrowings: 20000.00
BLDS.V balance_sheet (annual, 2022-03-31) — Other Equity Interest: 2974251.00
BLDS.V income_statement (annual, 2022-03-31) — Other Gand A: 147030.00
BLDS.V income_statement (annual, 2022-03-31) — Other Income Expense: 49878.00
BLDS.V cash_flow (annual, 2022-03-31) — Other Non Cash Items: 4018.00
BLDS.V balance_sheet (annual, 2022-03-31) — Other Non Current Assets: 24437.00
BLDS.V income_statement (annual, 2022-03-31) — Other Operating Expenses: 483367.00